Global Ion Channel Modulators Market Research Report 2021

1 Ion Channel Modulators Market Overview

• 1.1 Product Overview and Scope of Ion Channel Modulators
• 1.2 Ion Channel Modulators Segment by Type
  • 1.2.1 Global Ion Channel Modulators Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Channel Blockers
  • 1.2.3 Channel Openers
• 1.3 Ion Channel Modulators Segment by Application
  • 1.3.1 Ion Channel Modulators Sales Comparison by Application: (2021-2027)
  • 1.3.2 Clinical Trials
  • 1.3.3 Hospital
  • 1.3.4 Other
• 1.4 Global Ion Channel Modulators Market Size Estimates and Forecasts
  • 1.4.1 Global Ion Channel Modulators Revenue 2016-2027
  • 1.4.2 Global Ion Channel Modulators Sales 2016-2027
  • 1.4.3 Ion Channel Modulators Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ion Channel Modulators Market Competition by Manufacturers

• 2.1 Global Ion Channel Modulators Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Ion Channel Modulators Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Ion Channel Modulators Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Ion Channel Modulators Manufacturing Sites, Area Served, Product Type
• 2.5 Ion Channel Modulators Market Competitive Situation and Trends
  • 2.5.1 Ion Channel Modulators Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Ion Channel Modulators Players Market Share by Revenue
  • 2.5.3 Global Ion Channel Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ion Channel Modulators Retrospective Market Scenario by Region

• 3.1 Global Ion Channel Modulators Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Ion Channel Modulators Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Ion Channel Modulators Market Facts & Figures by Country
  • 3.3.1 North America Ion Channel Modulators Sales by Country
  • 3.3.2 North America Ion Channel Modulators Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Ion Channel Modulators Market Facts & Figures by Country
  • 3.4.1 Europe Ion Channel Modulators Sales by Country
  • 3.4.2 Europe Ion Channel Modulators Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Ion Channel Modulators Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Ion Channel Modulators Sales by Region
  • 3.5.2 Asia Pacific Ion Channel Modulators Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Ion Channel Modulators Market Facts & Figures by Country
  • 3.6.1 Latin America Ion Channel Modulators Sales by Country
  • 3.6.2 Latin America Ion Channel Modulators Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Ion Channel Modulators Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Ion Channel Modulators Sales by Country
  • 3.7.2 Middle East and Africa Ion Channel Modulators Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Ion Channel Modulators Historic Market Analysis by Type

• 4.1 Global Ion Channel Modulators Sales Market Share by Type (2016-2021)
• 4.2 Global Ion Channel Modulators Revenue Market Share by Type (2016-2021)
• 4.3 Global Ion Channel Modulators Price by Type (2016-2021)

5 Global Ion Channel Modulators Historic Market Analysis by Application

• 5.1 Global Ion Channel Modulators Sales Market Share by Application (2016-2021)
• 5.2 Global Ion Channel Modulators Revenue Market Share by Application (2016-2021)
• 5.3 Global Ion Channel Modulators Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Pfizer, Inc. (US)
  • 6.1.1 Pfizer, Inc. (US) Corporation Information
  • 6.1.2 Pfizer, Inc. (US) Description and Business Overview
  • 6.1.3 Pfizer, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Pfizer, Inc. (US) Product Portfolio
  • 6.1.5 Pfizer, Inc. (US) Recent Developments/Updates
• 6.2 Neusentis, Inc. (US)
  • 6.2.1 Neusentis, Inc. (US) Corporation Information
  • 6.2.2 Neusentis, Inc. (US) Description and Business Overview
  • 6.2.3 Neusentis, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Neusentis, Inc. (US) Product Portfolio
  • 6.2.5 Neusentis, Inc. (US) Recent Developments/Updates
• 6.3 AstraZeneca (UK)
  • 6.3.1 AstraZeneca (UK) Corporation Information
  • 6.3.2 AstraZeneca (UK) Description and Business Overview
  • 6.3.3 AstraZeneca (UK) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 AstraZeneca (UK) Product Portfolio
  • 6.3.5 AstraZeneca (UK) Recent Developments/Updates
• 6.4 Aurora Biomed, Inc. (Canada)
  • 6.4.1 Aurora Biomed, Inc. (Canada) Corporation Information
  • 6.4.2 Aurora Biomed, Inc. (Canada) Description and Business Overview
  • 6.4.3 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Aurora Biomed, Inc. (Canada) Product Portfolio
  • 6.4.5 Aurora Biomed, Inc. (Canada) Recent Developments/Updates
• 6.5 CalciMedica, Inc. (US)
  • 6.5.1 CalciMedica, Inc. (US) Corporation Information
  • 6.5.2 CalciMedica, Inc. (US) Description and Business Overview
  • 6.5.3 CalciMedica, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 CalciMedica, Inc. (US) Product Portfolio
  • 6.5.5 CalciMedica, Inc. (US) Recent Developments/Updates
• 6.6 Cellectricon AB (Sweden)
  • 6.6.1 Cellectricon AB (Sweden) Corporation Information
  • 6.6.2 Cellectricon AB (Sweden) Description and Business Overview
  • 6.6.3 Cellectricon AB (Sweden) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Cellectricon AB (Sweden) Product Portfolio
  • 6.6.5 Cellectricon AB (Sweden) Recent Developments/Updates
• 6.7 Convergence Pharmaceuticals Limited (UK)
  • 6.6.1 Convergence Pharmaceuticals Limited (UK) Corporation Information
  • 6.6.2 Convergence Pharmaceuticals Limited (UK) Description and Business Overview
  • 6.6.3 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Convergence Pharmaceuticals Limited (UK) Product Portfolio
  • 6.7.5 Convergence Pharmaceuticals Limited (UK) Recent Developments/Updates
• 6.8 Cytocentrics AG (Germany)
  • 6.8.1 Cytocentrics AG (Germany) Corporation Information
  • 6.8.2 Cytocentrics AG (Germany) Description and Business Overview
  • 6.8.3 Cytocentrics AG (Germany) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cytocentrics AG (Germany) Product Portfolio
  • 6.8.5 Cytocentrics AG (Germany) Recent Developments/Updates
• 6.9 Evotec AG (Germany)
  • 6.9.1 Evotec AG (Germany) Corporation Information
  • 6.9.2 Evotec AG (Germany) Description and Business Overview
  • 6.9.3 Evotec AG (Germany) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Evotec AG (Germany) Product Portfolio
  • 6.9.5 Evotec AG (Germany) Recent Developments/Updates
• 6.10 flyion GmbH (Germany)
  • 6.10.1 flyion GmbH (Germany) Corporation Information
  • 6.10.2 flyion GmbH (Germany) Description and Business Overview
  • 6.10.3 flyion GmbH (Germany) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 flyion GmbH (Germany) Product Portfolio
  • 6.10.5 flyion GmbH (Germany) Recent Developments/Updates
• 6.11 GlaxoSmithKline Plc. (UK)
  • 6.11.1 GlaxoSmithKline Plc. (UK) Corporation Information
  • 6.11.2 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Description and Business Overview
  • 6.11.3 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 GlaxoSmithKline Plc. (UK) Product Portfolio
  • 6.11.5 GlaxoSmithKline Plc. (UK) Recent Developments/Updates
• 6.12 Nanion Technologies GmbH (Germany)
  • 6.12.1 Nanion Technologies GmbH (Germany) Corporation Information
  • 6.12.2 Nanion Technologies GmbH (Germany) Ion Channel Modulators Description and Business Overview
  • 6.12.3 Nanion Technologies GmbH (Germany) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Nanion Technologies GmbH (Germany) Product Portfolio
  • 6.12.5 Nanion Technologies GmbH (Germany) Recent Developments/Updates
• 6.13 NeuroSearch A/S (Denmark)
  • 6.13.1 NeuroSearch A/S (Denmark) Corporation Information
  • 6.13.2 NeuroSearch A/S (Denmark) Ion Channel Modulators Description and Business Overview
  • 6.13.3 NeuroSearch A/S (Denmark) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 NeuroSearch A/S (Denmark) Product Portfolio
  • 6.13.5 NeuroSearch A/S (Denmark) Recent Developments/Updates
• 6.14 Novartis AG (Switzerland)
  • 6.14.1 Novartis AG (Switzerland) Corporation Information
  • 6.14.2 Novartis AG (Switzerland) Ion Channel Modulators Description and Business Overview
  • 6.14.3 Novartis AG (Switzerland) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Novartis AG (Switzerland) Product Portfolio
  • 6.14.5 Novartis AG (Switzerland) Recent Developments/Updates
• 6.15 Parion Sciences, Inc. (US)
  • 6.15.1 Parion Sciences, Inc. (US) Corporation Information
  • 6.15.2 Parion Sciences, Inc. (US) Ion Channel Modulators Description and Business Overview
  • 6.15.3 Parion Sciences, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Parion Sciences, Inc. (US) Product Portfolio
  • 6.15.5 Parion Sciences, Inc. (US) Recent Developments/Updates
• 6.16 Sanofi (France)
  • 6.16.1 Sanofi (France) Corporation Information
  • 6.16.2 Sanofi (France) Ion Channel Modulators Description and Business Overview
  • 6.16.3 Sanofi (France) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Sanofi (France) Product Portfolio
  • 6.16.5 Sanofi (France) Recent Developments/Updates
• 6.17 Targacept, Inc. (US)
  • 6.17.1 Targacept, Inc. (US) Corporation Information
  • 6.17.2 Targacept, Inc. (US) Ion Channel Modulators Description and Business Overview
  • 6.17.3 Targacept, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Targacept, Inc. (US) Product Portfolio
  • 6.17.5 Targacept, Inc. (US) Recent Developments/Updates
• 6.18 Xention Limited (UK)
  • 6.18.1 Xention Limited (UK) Corporation Information
  • 6.18.2 Xention Limited (UK) Ion Channel Modulators Description and Business Overview
  • 6.18.3 Xention Limited (UK) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Xention Limited (UK) Product Portfolio
  • 6.18.5 Xention Limited (UK) Recent Developments/Updates
• 6.19 Zalicus, Inc. (US)
  • 6.19.1 Zalicus, Inc. (US) Corporation Information
  • 6.19.2 Zalicus, Inc. (US) Ion Channel Modulators Description and Business Overview
  • 6.19.3 Zalicus, Inc. (US) Ion Channel Modulators Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Zalicus, Inc. (US) Product Portfolio
  • 6.19.5 Zalicus, Inc. (US) Recent Developments/Updates

7 Ion Channel Modulators Manufacturing Cost Analysis

• 7.1 Ion Channel Modulators Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Ion Channel Modulators
• 7.4 Ion Channel Modulators Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Ion Channel Modulators Distributors List
• 8.3 Ion Channel Modulators Customers

9 Ion Channel Modulators Market Dynamics

• 9.1 Ion Channel Modulators Industry Trends
• 9.2 Ion Channel Modulators Growth Drivers
• 9.3 Ion Channel Modulators Market Challenges
• 9.4 Ion Channel Modulators Market Restraints

10 Global Market Forecast

• 10.1 Ion Channel Modulators Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Ion Channel Modulators by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Ion Channel Modulators by Type (2022-2027)
• 10.2 Ion Channel Modulators Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Ion Channel Modulators by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Ion Channel Modulators by Application (2022-2027)
• 10.3 Ion Channel Modulators Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Ion Channel Modulators by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Ion Channel Modulators by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List